We performed a 5-question survey of 21 dermatologists to gauge usage of drugs and devices for the treatment of common dermatological conditions and for aesthetic procedures.
Number of pages:11
We performed a 5-question survey of 21 dermatologists on treatment practices for acne, rosacea, actinic keratosis, and aesthetic procedures.
Drugs covered include Aczone (AGN), Finacea (Bayer)/Azelex (AGN), Differin (Galderma and generics), Epiduo (Galderma), and oral isotretinoin. Physicians also provided usage information on ablative and non-ablative laser skin resurfacing, photodynamic therapy, and dermal fillers marketed by Allergan (AGN), Valeant (VRX), and Merz.
This survey was performed in conjunction with MedDeviceTracker, a forthcoming product that will provide coverage of the medtech (medical device and diagnostic) marketplace.
Figure: Percent of acne patients receiving the given medication
This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.